SEC Form 5 · accession 0001209191-16-098684
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John F Crowley
Officer — Chairman & CEO · Director
Period of report
Dec 31, 2015
Accepted (ET)
Feb 16, 2016 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 30, 2015 | A | 25,088 | $13.75 | A | 121,780 | D | |
| Common StockF2 | Dec 23, 2015 | G | 25,088 | $0.00 | D | 96,692 | D | |
| Common StockF3 | Dec 23, 2015 | G | 10,000 | $0.00 | D | 86,692 | D | |
| Common Stock | holding | — | — | — | 64,895 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. Crowley acquired 25,088 shares of common stock on September 30, 2015 in connection with Amicus Therapeutics, Inc.'s acquisition of Scioderm, Inc.
- F2Mr. Crowley donated 25,088 shares to various 501(c)(3) charities for the benefit of children with Epidermolysis Bullosa (EB) rare disease.
- F3Mr. Crowley donated 10,000 shares to the Make-A-Wish Foundation of America.